U.S. Dialysis Market Size, By Type, By Product & Service, By End-use, Industry Analysis Report, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032

Description

The U.S. Dialysis Market is expected to grow considerably through 2032 owing to the surging prevalence of diabetes in the U.S. given a drastic change in lifestyle.

Growing incidences of chronic diseases, scientific and technical breakthroughs in dialysis in the United States, an aging population, as well as rising demand for at-home dialysis are some of the key factors expected to drive industry growth. Additionally, rising disposable income and higher healthcare costs are anticipated to improve the U.S. dialysis industry outlook.

Leading market players are investing in R&D initiatives to develop breakthrough technologies to improve the quality of patient care. For instance, in March 2021, Baxter received U.S. FDA approval in March 2021 for its AK98 (Artificial kidney 98) dialysis machine. The device is meant to be employed for intermittent hemodialysis as well as isolated ultrafiltration therapies for individuals with acute or chronic fluid overload or renal failure. The move is likely to bolster the company's prominence in the market.

The U.S. dialysis market has been divided in terms of type, application, end-use, and zone.

Based on type, peritoneal dialysis is anticipated to expand through the forecast timeline due to the increasing use of innovative and technically advanced devices during medical procedures. Moreover, peritoneal dialysis boasts of several benefits over hemodialysis, including fewer dietary restrictions, more freedom over lifestyle choices, and no need for frequent hospital visits.

With respect to application, the consumables segment held more than USD 5.8 billion in revenue in 2022 credited to the rising requirement for dialysis therapy as a form of kidney disease treatment. The market expansion is expedited by developments in consumables including catheters, which guarantee effective therapy. The use of dialysis therapy will increase demand for the supplies needed for the operation, fueling segmental growth.

In terms of end-use, the home dialysis segment is poised to grow significantly over the review years attributed to the several advantages it offers, including better quality of life, lower travel costs, flexibility, and simple patient mobility, leading to a rise in its adoption.

Based on zone, the Pacific Central dialysis market is speculated to grow at more than 3.5% CAGR from 2023 to 2032 driven by the massive disease burden in the region, rising privatization, rising health insurance penetration, aggravating efforts to increase the number of qualified health care personnel, and the rapidly aging population susceptible to several chronic illnesses.

Product Code: 5091

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 U.S. dialysis industry 360 degree synopsis, 2018-2032
- 2.1.1 Business trends
- 2.1.2 Type trends
- 2.1.3 Product & service trends
- 2.1.4 End-use trends
- 2.1.5 Zonal trends

Chapter 3 US Dialysis Industry Insights

3.1 Industry landscape
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
  - 3.2.1.2 Increasing incidence of diabetes
  - 3.2.1.3 Shortage of donor kidneys
  - 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
  - 3.2.1.5 R&D investments
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Product recalls
  - 3.2.2.2 Complications in the treatment
3.3 Growth potential analysis
- 3.3.1 By type
- 3.3.2 By product & services
- 3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
3.6 Reimbursement scenario
3.7 Value chain analysis
3.8 Future market trends
3.9 Technology landscape
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Strategy dashboard, 2022

Chapter 5 US Dialysis Market, By Type

5.1 Key type trends
5.2 Hemodialysis
- 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Peritoneal Dialysis
- 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 US Dialysis Market, By Product and Services

6.1 Key product and services trends
6.2 Equipment
- 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.2.2 Dialysis machines
  - 6.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.2.3 Water treatment systems
  - 6.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.2.4 Others
  - 6.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Consumables
- 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.2 Dialyzers
  - 6.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.3 Catheters
  - 6.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.4 Access products
  - 6.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.5 Concentrates
  - 6.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.3.6 Others
  - 6.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Services
- 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.4.2 Acute dialysis
  - 6.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
- 6.4.3 Chronic dialysis
  - 6.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 US Dialysis Market, By End-use

7.1 Key end-use trends
7.2 In-center dialysis
- 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Home dialysis
- 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 US Dialysis Market, By Zone

8.1 Key zonal trends
8.2 East North Central
- 8.2.1 Illinois
- 8.2.2 Indiana
- 8.2.3 Michigan
- 8.2.4 Ohio
- 8.2.5 Wisconsin
8.3 West South Central
- 8.3.1 Arkansas
- 8.3.2 Louisiana
- 8.3.3 Oklahoma
- 8.3.4 Texas
8.4 South Atlantic
- 8.4.1 Delaware
- 8.4.2 Florida
- 8.4.3 Georgia
- 8.4.4 Maryland
- 8.4.5 North Carolina
- 8.4.6 South Carolina
- 8.4.7 Virginia
- 8.4.8 West Virginia
- 8.4.9 Washington, D.C.
8.5 North East
- 8.5.1 Connecticut
- 8.5.2 Maine
- 8.5.3 Massachusetts
- 8.5.4 New Hampshire
- 8.5.5 Rhode Island
- 8.5.6 Vermont
- 8.5.7 New Jersey
- 8.5.8 New York
- 8.5.9 Pennsylvania
8.6 East South Central
- 8.6.1 Alabama
- 8.6.2 Kentucky
- 8.6.3 Mississippi
- 8.6.4 Tennessee
8.7 West North Central
- 8.7.1 Iowa
- 8.7.2 Kansas
- 8.7.3 Minnesota
- 8.7.4 Missouri
- 8.7.5 Nebraska
- 8.7.6 North Dakota
- 8.7.7 South Dakota
8.8 Pacific Central
- 8.8.1 Alaska
- 8.8.2 California
- 8.8.3 Hawaii
- 8.8.4 Oregon
- 8.8.5 Washington
8.9 Mountain States
- 8.9.1 Arizona
- 8.9.2 Colorado
- 8.9.3 Utah
- 8.9.4 Nevada
- 8.9.5 New Mexico
- 8.9.6 Idaho
- 8.9.7 Montana
- 8.9.8 Wyoming

Chapter 9 Company Profiles

9.1 Asahi Kasei Corporation
9.2 American Renal Associates
9.3 B. Braun Melsungen AG
9.4 Baxter International Inc.
9.5 DaVita Inc.
9.6 Becton, Dickinson and Company
9.7 Fresenius Medical Care AG & Co.
9.8 Medtronic plc
9.9 Nipro Corporation
9.10 Sanderling Renal Services
9.11 Toray Industries Inc.
9.12 U.S. Renal Care, Inc.